- Home
- Publications
- Publication Search
- Publication Details
Title
Evinacumab for treatment of familial hypercholesterolemia
Authors
Keywords
-
Journal
Expert Review of Cardiovascular Therapy
Volume 19, Issue 8, Pages 739-751
Publisher
Informa UK Limited
Online
2021-07-13
DOI
10.1080/14779072.2021.1955349
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Marked plaque regression in homozygous familial hypercholesterolemia
- (2021) Laurens F. Reeskamp et al. ATHEROSCLEROSIS
- Targeting angiopoietin‐like 3 in atherosclerosis: From bench to bedside
- (2021) Ping Ling et al. DIABETES OBESITY & METABOLISM
- Beyond Statins and PCSK9 Inhibitors: Updates in Management of Familial and Refractory Hypercholesterolemias
- (2021) Fabiana Rached et al. Current Cardiology Reports
- Long-Term Evolocumab in Patients With Familial Hypercholesterolemia
- (2020) Raul D. Santos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia
- (2020) Massimiliano Ruscica et al. PHARMACOLOGICAL RESEARCH
- Inclisiran Durably Lowers Low-Density Lipoprotein Cholesterol and Proprotein Convertase Subtilisin/Kexin Type 9 Expression in Homozygous Familial Hypercholesterolemia
- (2020) G. Kees Hovingh et al. CIRCULATION
- Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association
- (2020) Emily E. Brown et al. Journal of Clinical Lipidology
- Worldwide Prevalence of Familial Hypercholesterolemia
- (2020) Sabina O. Beheshti et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
- (2020) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
- (2020) Frederick J. Raal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Very high-risk familial hypercholesterolaemia patients in real life: The remaining gap in achieving the current LDL-C targets despite the use of PCSK9 inhibitors
- (2020) Loukianos S. Rallidis et al. ATHEROSCLEROSIS
- Evinacumab for Homozygous Familial Hypercholesterolemia
- (2020) Frederick J. Raal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evinacumab in Patients with Refractory Hypercholesterolemia
- (2020) Robert S. Rosenson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia
- (2019) Zahid Ahmad et al. CIRCULATION
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry
- (2019) P. Barton Duell et al. ATHEROSCLEROSIS
- Treatment of children with heterozygous familial hypercholesterolemia.
- (2019) Željko Reiner et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia
- (2019) Ilse K. Luirink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiopoietin-like proteins as therapeutic targets for cardiovascular disease: focus on lipid disorders
- (2019) Marco Bruno Morelli et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice
- (2019) Marianne G. Pouwer et al. JOURNAL OF LIPID RESEARCH
- Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia
- (2019) Mary P. McGowan et al. Journal of the American Heart Association
- Hepatic Overexpression of Endothelial Lipase Lowers High-Density Lipoprotein but Maintains Reverse Cholesterol Transport in MiceHighlights
- (2018) Shunichi Takiguchi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The complex molecular genetics of familial hypercholesterolaemia
- (2018) Amanda J. Berberich et al. Nature Reviews Cardiology
- Treatment of children with homozygous familial hypercholesterolaemia
- (2018) Željko Reiner European Journal of Preventive Cardiology
- Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
- (2018) Antonio J. Vallejo-Vaz et al. ATHEROSCLEROSIS
- Clinical Genetic Testing for Familial Hypercholesterolemia
- (2018) Amy C. Sturm et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Managing the challenging homozygous familial hypercholesterolemia patient: Academic insights and practical approaches for a severe dyslipidemia, a National Lipid Association Masters Summit
- (2017) G. Kees Hovingh et al. Journal of Clinical Lipidology
- ANGPTL3 Deficiency and Protection Against Coronary Artery Disease
- (2017) Nathan O. Stitziel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia
- (2017) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides
- (2017) Mark J. Graham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
- (2017) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
- (2017) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients
- (2016) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011–2012
- (2016) Nathan D. Wong et al. Journal of Clinical Lipidology
- Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel
- (2016) Raul D Santos et al. Lancet Diabetes & Endocrinology
- The Agenda for Familial Hypercholesterolemia
- (2015) Samuel S. Gidding et al. CIRCULATION
- National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
- (2015) Terry A. Jacobson et al. Journal of Clinical Lipidology
- Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion
- (2015) Yan Wang et al. JOURNAL OF LIPID RESEARCH
- ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys
- (2015) Viktoria Gusarova et al. JOURNAL OF LIPID RESEARCH
- Mendelian randomization of blood lipids for coronary heart disease
- (2014) Michael V. Holmes et al. EUROPEAN HEART JOURNAL
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- (2014) M. Cuchel et al. EUROPEAN HEART JOURNAL
- Ten-Year Follow-up After Initiation of Statin Therapy in Children With Familial Hypercholesterolemia
- (2014) D. Meeike Kusters et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Carotid Intima-Media Thickness in Children With Familial Hypercholesterolemia
- (2013) Dorothé M. Kusters et al. CIRCULATION RESEARCH
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
- (2013) B. G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Mutations in theANGPTL3Gene and Familial Combined Hypolipidemia: A Clinical and Biochemical Characterization
- (2012) Ilenia Minicocci et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
- (2012) Benjamin F Voight et al. LANCET
- Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
- (2011) Anne C. Goldberg et al. Journal of Clinical Lipidology
- The LDL Receptor
- (2009) Joseph L. Goldstein et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started